Oppenheimer Holdings

OPY

Market cap $957M

Seasoned municipal finance leader joins the firm's Public Finance Investment Banking Group and will be based in Los Angeles NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY), today announced it has hired Vien Le as Managing Director in the firm's Public Finance Investment Banking Group. Le will be based in Oppenheimer's Los Angeles office and will report to Beth Coolidge, Managing Director and Head of Public Finance.

Oppenheimer Holdings delivered strong quarterly results, driven by operating leverage and a sharp rebound in capital markets, particularly ECM. Wealth management benefited from higher AUM and a favorable product mix. OPY trades at a significant valuation discount to a peer like Raymond James, with forward PE around 6.4x and annualized PE below 4x.

NEW YORK, Jan. 30, 2026 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the fourth quarter of 2025 compared with net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024, an increase of 593.1%. Revenue for the fourth quarter of 2025 was $472.6 million compared to revenue of $375.4 million for the fourth quarter of 2024, an increase of 25.9%.

NEW YORK , Dec. 12, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) today announced that its Board of Directors has declared a special cash dividend on OPY Class A non-voting and Class B voting common stock of $1.00 per share, payable January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. The aggregate payment will be approximately $10.5 million.

The addition of well-respected biotech expert strengthens one of Oppenheimer's longest-standing franchise areas NEW YORK , Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE: OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City.

Veteran equity markets leader joins to oversee trading operations  and advance cross-platform growth initiatives NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. – a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings (NYSE: OPY) — today announced that Keith Peterson has joined the firm as Managing Director and Head of Cash Equity Sales and Trading. He will report to John Hellier, Senior Managing Director and Head of Equities.

NEW YORK , Oct. 31, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the third quarter of 2025, compared with net income of $24.5 million or $2.38 basic earnings per share for the third quarter of 2024. Third quarter 2025 results were significantly impacted by higher pre-tax compensation expenses for liability-based awards totaling $13.5 million or $0.95 basic earnings per share (after tax), attributable to an increase in the OPY Class A share price (increased $8.30 per share during the quarter).

Addition of respected industry veteran highlights the rapid expansion of the firm's Public Finance team NEW YORK , Oct. 29, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY), today announced it has hired Guy T. Logan to serve as Managing Director, Head of Infrastructure & Mid-Atlantic Region within the firm's Public Finance Investment Banking Division.

Oppenheimer delivered a strong quarter, benefiting from a capital and securities market recovery, increased AUM, and robust sales and trading activity. OPY trades at a low P/E and P/B, it's clearly quite undervalued and may be an interesting target in industry consolidations, though that's speculative. While S&T may not maintain its momentum into the coming quarter, we expect good things from advisory and from wealth management.

Seasoned industry professional brings 27 years of experience to expanding Healthcare platform NEW YORK , Oct. 6, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") — a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — today announced that James Yoo has been named a Managing Director within its Healthcare Equity Capital Markets Investment Banking Group. In this role, Mr.